Correlation of iron in the hippocampus with MMSE in patients with alzheimer's disease

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 4, 2009, Pages 793-798

  Ding, Bei ^a   Chen, Ke Min ^a   Ling, Hua Wei ^a   Sun, Fei ^b,d   Li, Xia ^c   Wan, Tao ^c   Chai, Wei Min ^a   Zhang, Huan ^a   Zhan, Ying ^a   Guan, Yong Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b GE HEALTHCARE   (China)

^c Economic and Technologic   (China)

^d SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Alzheimer's disease; Brain iron; Magnetic susceptibility; Phase image

Indexed keywords

IRON;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE DURATION; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PRIORITY JOURNAL; PUTAMEN; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IRON; MALE; PROSPECTIVE STUDIES; PUTAMEN; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 65249141710     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21730     Document Type: Article

References (27)

1. Giannakopoulos P, Hof PR, Giannakopoulos AS, et al. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol 1995;52:1150- 1159.
2. Pearson RCA, Esiri MM, Hiorns RW, et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 1985;82:4531-4534.
3. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-256.
4. Connor JR, Menzies SL, St Martin SM, et al. A histochemical study of iron, transferrin, and ferritin in Alzheimer's disease brains. J Neurosci Res 1992;31:75-83.
5. Deibel MA, Ehmann WD, Markesbery WR. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 1996; 143:137-142.
6. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997;760:298-303.
7. Sayre LM, Perry G, Harris PL, et al. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000;74: 270-279.
8. Collingwood JF, Mikhaylova A, Davidson M, et al. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 2005;7:267-272.
9. Honda K, Casadesus G, Petersen RB, et al. Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci 2004; 1012:179-182.
10. Doraiswamy PM, Finefrock AE. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 2004; 3:431-434.
11. Zheng H, Weiner LM, Bar-AM O, et al. Design, synthesis, and evaluation of a novel bifunctional iron-chelator as a potential agent for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorg Med Chem 2005;13:773-783.
12. Liu G, Garrett MR, Men P, et al. Nanoparticle and other metal chelation therapeutics in Alzheimer's disease. Biochem Biophys Acta 2005;1741:246-252.
13. Haacke EM, Cheng YC, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25.
14. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in mgnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007; 26:256 -264.
15. Jensen JH, Chandra R, Ramani A, et al. Magnetic field correlation imaging. Magn Reson Med 2006;55:1350-1361.
16. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-450.
17. Xu X, Wang Q, Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study. Neuroimaging 2008;40:35-42.
18. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. Hyman BT, Van Horsen GW, Damasio AR, et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
20. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 1990;83:445-457.
21. Frisoni GB, Sabattoli F, Lee AD, et al. In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study. NeuroImage 2006;32:104-110.
22. Xu Y, Valentino DJ, Scher AI, et al. Age effects on hippocampal structural changes in old men: the HAAS. NeuroImage 2008;40: 1003-1015.
23. Laakso MP, Lehtovirta M, Partanen K, et al. Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study. Biol Psychiatry 2000;47:557-561.
24. Tapiola T, Pennanen C, Tapiola M, et al. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study. Neurobiol Aging 2008;29:31-38.
25. House MJ, St. Pierre TG, Foster JK, et al. Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. AJNR Am J Neuroradiol 2006;27:430-439.
26. Laasko MP, Partanen K, Soininen H, et al. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment. Neurobiol Aging 1996;17:535-540.
27. Schenck JF, Zimmerman EA, Li Z, et al. High-field magnetic resonance imaging of brain iron in alzheimer disease. Top Magn Reson Imaging 2006;17:41-50.